Riskpilot← Back to searchSign inGet full accessMEDIVA AS
ASActiveOrg 913439201Grønnegata 10, 9008 TromsøOther human health activities n.e.c. · NACE 8699Est. 20147 employees
Revenue 2025
NOK 10,1M
+8% vs 2024
EBITDA margin
28.4%
-6% vs 2024
Equity ratio
70.6%
Financial strength
Net profit 2025
NOK 1,8M
-13% vs 2024
| Revenue | NOK 10,1M | +8% |
| EBITDA | NOK 2,9M | -6% |
| Net profit | NOK 1,8M | -13% |
| Total assets | NOK 10,6M | +1% |
| Equity | NOK 7,5M | +10% |
| Employees | 7 | — |
Legal name
MEDIVA AS
Org number
913439201
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
28. mars 2014
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Alt innen andre helsetjenester, som medisinsk injeksjonsbehandling og utleie av sykepleier.
Address
Grønnegata 10, 9008 Tromsø
Email
post@mediva.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 433 | 4 330 | 5 229 | 5 694 | 5 712 | 6 551 | 7 011 | 6 143 | 7 041 | 8 192 | 9 329 | 10 050 |
| Staff expenses | −991 | −914 | −1 356 | −1 243 | −1 384 | −1 470 | −1 730 | −2 078 | −2 293 | −2 594 | −2 886 | −3 127 |
| EBITDA | 840 | 1 535 | 1 529 | 1 910 | 1 520 | 2 099 | 2 290 | 1 645 | 2 135 | 1 869 | 3 051 | 2 856 |
| Depreciation & amort. | −0 | −0 | −38 | −129 | −150 | −147 | −124 | −118 | −172 | −260 | −404 | −523 |
| EBIT | 840 | 1 535 | 1 492 | 1 781 | 1 370 | 1 952 | 2 166 | 1 527 | 1 963 | 1 609 | 2 648 | 2 333 |
| Net financials | 0 | 3 | −41 | −116 | −87 | −74 | −38 | 0 | 5 | 36 | 64 | 67 |
| Profit before tax | 841 | 1 538 | 1 450 | 1 665 | 1 283 | 1 879 | 2 128 | 1 527 | 1 968 | 1 645 | 2 712 | 2 399 |
| Tax | 225 | 416 | 363 | 400 | 297 | 429 | 477 | 326 | 444 | 339 | 596 | 550 |
| Net profit | 615 | 1 122 | 1 088 | 1 264 | 986 | 1 450 | 1 652 | 1 201 | 1 525 | 1 306 | 2 116 | 1 849 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 231 | 2 052 | 5 548 | 5 872 | 6 567 | 7 322 | 6 634 | 6 789 | 8 598 | 8 935 | 10 460 | 10 563 |
| Equity | 545 | 968 | 1 855 | 2 620 | 3 106 | 3 856 | 5 008 | 5 709 | 6 233 | 6 739 | 6 805 | 7 454 |
| Long-term debt | 0 | 0 | 2 866 | 2 198 | 2 090 | 1 943 | 0 | 0 | 0 | 9 | 16 | 0 |
| Short-term debt | 686 | 1 084 | 826 | 1 054 | 1 371 | 1 523 | 1 626 | 1 080 | 2 365 | 2 186 | 3 639 | 3 109 |
| Total debt | 686 | 1 085 | 3 692 | 3 252 | 3 461 | 3 466 | 1 626 | 1 080 | 2 365 | 2 195 | 3 655 | 3 109 |
EBITDA margin
28.4%
This company
15.8%
Market median
+80% vs market
20142025
Equity ratio
70.6%
This company
38.2%
Market median
+85% vs market
20142025
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20142025
Net profit margin
18.4%
This company
8.1%
Market median
+127% vs market
20142025
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
20142025
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20142025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-03-10 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MF Deputy Member | Deputy Member | 2014 | — | — |
ME Deputy Member | Deputy Member | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2014 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDIVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marlene Franek Elvevold | Deputy Member | 0 companies |
| Marlene Elvevold | Deputy Member | 0 companies |
| Marianne Brattli | Chairman | 0 companies |